What Laboratory Tests Are Needed Before Starting HRT?

The laboratory tests needed before starting hormone replacement therapy (HRT) depend on your symptoms, age, medical history, and the type of hormone treatment being considered. There is no single laboratory panel that every patient needs.

For women considering hormone therapy for perimenopause or menopause, treatment can often be considered based primarily on symptoms, menstrual history, age, medical history, and individual risk factors. Routine estrogen, progesterone, or follicle-stimulating hormone (FSH) testing is not necessarily required.

For men being evaluated for testosterone replacement therapy (TRT), laboratory confirmation is more important. Testosterone deficiency should generally be supported by symptoms along with consistently low testosterone concentrations measured appropriately before treatment is prescribed.

At Ask Dr. Hu, laboratory testing is considered alongside your symptoms, health history, medications, treatment goals, and risk factors rather than being interpreted in isolation.

Does Everyone Need the Same Laboratory Tests Before HRT?

No.

Hormone replacement therapy includes several different types of treatment. A woman considering estrogen for menopausal hot flashes may require a very different evaluation from a man considering testosterone replacement therapy.

Before deciding which tests are appropriate, a physician may consider:

• Your age and biological sex

• Symptoms

• Menstrual or menopause history

• Medical and surgical history

• Current medications and supplements

• Family history

• Cardiovascular and metabolic risk factors

• Cancer history

• Blood-clotting history

• Fertility plans

• Previous laboratory results

• The specific hormone being considered

This is one reason HRT should be individualized rather than prescribed according to a standardized hormone panel.

What Laboratory Tests May Be Considered Before HRT for Women?

One of the most common misconceptions about menopausal hormone therapy is that every woman needs extensive hormone testing before treatment begins.

For otherwise healthy women experiencing typical symptoms of perimenopause or menopause, routine hormone-level testing is often unnecessary.

The American College of Obstetricians and Gynecologists (ACOG) notes that hormone testing generally is not recommended before starting hormone therapy for typical menopausal symptoms because hormone concentrations can fluctuate considerably during the menopause transition.

Instead, evaluation usually places greater emphasis on symptoms, menstrual history, age, medical history, risk factors, and whether another condition could be causing similar symptoms.

Estradiol and FSH

Estradiol and FSH can provide useful information in selected situations, but they are not automatically required for every woman considering menopausal hormone therapy.

Testing may be more useful when the clinical situation is unclear—for example, when menstrual history cannot be used reliably, menopause occurs unusually early, or another endocrine or reproductive condition is suspected.

A single hormone level should not generally be viewed as a complete picture of hormone health.

Thyroid Testing

A thyroid-stimulating hormone (TSH) test may be appropriate when symptoms such as fatigue, temperature intolerance, menstrual changes, sleep disturbance, weight changes, or mood changes could potentially be related to thyroid disease rather than menopause alone.

This is an example of why laboratory testing before HRT is sometimes used not simply to measure reproductive hormones, but to look for other medical explanations for the patient's symptoms.

Complete Blood Count

A complete blood count (CBC) may be considered when clinically indicated, particularly when there is abnormal or heavy menstrual bleeding, unexplained fatigue, suspected anemia, or another medical reason to evaluate blood-cell counts.

Comprehensive Metabolic Panel

A comprehensive metabolic panel (CMP) provides information about kidney function, liver function, electrolytes, glucose, and several other metabolic markers.

Whether it is necessary specifically because of HRT depends on the individual patient and medication being considered. However, reviewing general health and organ function can be useful when developing an overall treatment plan.

Blood Sugar and Cardiovascular Risk Testing

Depending on age and medical history, testing may also include:

• Hemoglobin A1c or fasting glucose

• Lipid panel

• Other cardiovascular or metabolic testing when clinically indicated

These are not necessarily "hormone tests." They help the physician understand the patient's broader health and risk profile before treatment.

You can learn more about how blood testing fits into a larger medical evaluation in the Routine Laboratory Testing Resource Center.

Pregnancy Testing

For women who could potentially become pregnant, pregnancy status should be considered before beginning treatments that may be inappropriate during pregnancy.

Whether a pregnancy test is necessary depends on age, menstrual history, sexual and reproductive history, contraceptive use, and the therapy being considered.

Do Women Need Estrogen and Progesterone Levels Before Starting HRT?

Not necessarily.

Menopausal hormone therapy should not be reduced to trying to make estrogen or progesterone laboratory values reach a predetermined "optimal" number.

During perimenopause especially, hormone levels can fluctuate considerably. Symptoms, menstrual patterns, medical history, treatment response, and safety considerations are often more informative than an isolated blood level.

ACOG also cautions against using routine serum or saliva hormone testing simply to individualize dosing of compounded bioidentical menopausal hormone therapy when those measurements have not been shown to reliably guide treatment.

This does not mean hormone testing is never useful. It means testing should answer a specific clinical question rather than being ordered automatically.

What Laboratory Tests Are Needed Before Testosterone Replacement Therapy for Men?

Laboratory testing plays a more central role when evaluating men for testosterone replacement therapy.

Symptoms such as fatigue, reduced libido, erectile dysfunction, decreased muscle mass, low motivation, and difficulty concentrating can occur for many reasons. Testosterone therapy should therefore not be prescribed simply because someone has symptoms associated with "low T."

The Endocrine Society recommends diagnosing hypogonadism only when a man has compatible symptoms or signs and unequivocally and consistently low testosterone concentrations.

Total Testosterone

Total testosterone is usually the starting point.

Because testosterone concentrations vary throughout the day and from one day to another, a low result usually needs to be appropriately confirmed rather than relying on one isolated measurement.

For many men, this means obtaining testosterone measurements on separate mornings under appropriate testing conditions before establishing a diagnosis.

Free Testosterone

Free testosterone may be useful in selected patients, particularly when total testosterone is borderline or when conditions that affect sex hormone-binding globulin (SHBG) could make total testosterone more difficult to interpret.

Free testosterone is not necessarily required for every patient.

LH and FSH

Once testosterone deficiency has been established, luteinizing hormone (LH) and sometimes follicle-stimulating hormone (FSH) can help determine whether the problem is more likely arising from the testes or from the pituitary-hypothalamic system.

The Endocrine Society recommends measuring LH and FSH when distinguishing primary from secondary hypogonadism.

Prolactin

A prolactin level may be appropriate in certain men, particularly when testosterone is low and LH is low or inappropriately normal.

The American Urological Association recommends measuring prolactin in men with low testosterone accompanied by low or low-normal LH because this pattern can suggest a pituitary or hypothalamic cause that may require further evaluation.

CBC and Hematocrit

A CBC with hemoglobin and hematocrit is an important baseline consideration before testosterone therapy.

Testosterone can increase red blood cell production and hematocrit. An already elevated hematocrit may alter whether or how testosterone therapy is started.

Hematocrit should also be monitored after testosterone therapy begins.

PSA and Prostate Evaluation

Depending on the patient's age, individual prostate-cancer risk, symptoms, and preferences, prostate-specific antigen (PSA) testing and prostate evaluation may be appropriate before testosterone therapy.

The Endocrine Society recommends discussing prostate cancer risk and monitoring with appropriate men before treatment and incorporating patient-specific risk into the decision.

A high or unexpectedly changing PSA does not automatically mean prostate cancer is present, but it may require additional evaluation before or during therapy.

Are CMP, Thyroid, Cholesterol, and Diabetes Tests Needed Before TRT?

These tests may be useful even though they do not diagnose testosterone deficiency.

Symptoms attributed to low testosterone may sometimes be influenced by conditions such as thyroid disease, diabetes, metabolic dysfunction, anemia, sleep disorders, medication effects, obesity, or other underlying health problems.

Depending on the clinical picture, a physician may therefore consider tests such as:

• CBC

• CMP

• TSH

• Hemoglobin A1c or fasting glucose

• Lipid panel

• Additional endocrine testing when indicated

At Ask Dr. Hu, the exact testing strategy is based on the patient's clinical picture. Our Hormone Replacement Therapy program combines symptom assessment, medical history, appropriate laboratory testing, and ongoing monitoring rather than treating a laboratory number by itself.

Are Saliva or Urine Hormone Tests Required Before HRT?

Generally, specialty saliva or urine hormone testing is not routinely required before conventional menopausal hormone therapy or testosterone replacement therapy.

Certain specialty tests may have specific clinical applications, but more testing is not automatically better.

The most useful test is one that:

1. Answers a meaningful clinical question.

2. Has adequate reliability for that purpose.

3. Can change diagnosis, treatment, or monitoring.

ACOG has specifically raised concerns about using adjunctive hormone testing to dose compounded menopausal hormone therapy when results cannot reliably guide clinical management.

What Happens If My Laboratory Results Are Abnormal?

An abnormal laboratory result does not necessarily mean you cannot receive HRT.

Instead, it may indicate that additional evaluation is needed before treatment.

For example:

• Elevated hematocrit may need to be investigated before testosterone therapy.

• Abnormal thyroid results may suggest that thyroid disease is contributing to symptoms.

• Unexpectedly low testosterone with abnormal LH or prolactin could warrant evaluation for a pituitary or testicular disorder.

• Abnormal liver, kidney, glucose, or lipid results may influence medication selection or the overall treatment plan.

• Unexpected uterine bleeding may require evaluation rather than simply increasing or changing hormones.

The goal is not simply to "pass" the laboratory testing. The purpose is to understand the patient's health well enough to determine whether hormone therapy is appropriate and how treatment can be monitored safely.

Can Previous Laboratory Results Be Used?

Sometimes.

If you recently completed laboratory testing, bring those results to your hormone consultation. Your physician can determine whether they contain the information needed or whether anything should be repeated.

Whether older laboratory results remain useful depends on:

• How long ago they were obtained

• Whether your symptoms have changed

• Whether medications have changed

• Whether treatment has already begun

• Which hormone is being considered

• Whether a result needs confirmation

• Whether new medical conditions have developed

Bringing previous results can help avoid unnecessary duplicate testing.

If you are preparing for an evaluation, our Patient's Guide to Starting Hormone Replacement Therapy explains what to expect before and after treatment begins.

Will I Need More Blood Work After Starting HRT?

Often, yes.

Baseline testing and follow-up testing serve different purposes.

Testing before treatment may help establish a diagnosis, identify potential safety concerns, and create a baseline for comparison.

After treatment begins, laboratory testing may be used to:

• Evaluate treatment response

• Confirm that hormone exposure remains appropriate

• Monitor hematocrit during testosterone therapy

• Assess PSA when clinically appropriate

• Evaluate possible side effects

• Investigate new symptoms

• Determine whether medication changes are needed

The exact monitoring schedule depends on the medication, dose, route of administration, patient characteristics, and treatment response.

Hormone therapy therefore should not be viewed as a prescription that is started once and never reassessed. Ongoing clinical follow-up is an important part of appropriate treatment.

Frequently Asked Questions

Can I start HRT without laboratory testing?

It depends on the type of HRT and your clinical situation. Women with typical menopausal symptoms do not necessarily need reproductive hormone measurements before menopausal hormone therapy. Men being evaluated for testosterone deficiency generally require appropriately confirmed low testosterone before TRT is prescribed. Other baseline testing may be recommended based on health history and treatment type.

Do I need a full hormone panel before starting HRT?

Usually not. There is no universal "full hormone panel" that every patient needs. Testing should be selected according to your symptoms, medical history, age, reproductive status, and the specific therapy being considered.

Do women need FSH testing before menopause HRT?

Not routinely. In women with typical perimenopausal or menopausal symptoms, diagnosis can frequently be made clinically without FSH testing. Testing may become useful when the diagnosis is unclear or the clinical situation is unusual.

How many testosterone tests are needed before TRT?

A diagnosis of testosterone deficiency should be based on consistently low testosterone levels rather than a single isolated result. Repeat morning testing is commonly used to confirm a low testosterone concentration before treatment.

Why is hematocrit checked before testosterone therapy?

Testosterone therapy can increase red blood cell production and hematocrit. Establishing a baseline helps identify patients who may already have elevated hematocrit and provides a value for comparison during follow-up monitoring.

The Bottom Line

There is no single laboratory panel required for everyone before starting hormone replacement therapy.

For women considering menopausal hormone therapy, routine estrogen, progesterone, or FSH measurements are often unnecessary when the clinical picture clearly supports perimenopause or menopause.

For men considering testosterone replacement therapy, laboratory testing is essential to appropriately confirm testosterone deficiency and evaluate potential causes and safety considerations.

Additional testing—including CBC, CMP, thyroid testing, glucose or A1c, lipid testing, prolactin, LH, FSH, or PSA—may be appropriate depending on the patient and treatment being considered.

The best approach is to use laboratory testing selectively, interpret results in context, and combine them with symptoms, medical history, risk factors, medications, fertility considerations, and treatment goals.

For additional physician-written information, visit the Hormone Replacement Therapy Resource Center.

If you are considering treatment in Arizona, you can also learn more about personalized hormone replacement therapy at Ask Dr. Hu.

Medical Review & Editorial Standards

This article is intended to provide evidence-informed patient education and was developed using established clinical guidance regarding menopausal hormone therapy and testosterone deficiency.

Medical guidance referenced includes information from the American College of Obstetricians and Gynecologists (ACOG), The Endocrine Society, and the American Urological Association. Recommendations may change as new evidence becomes available, and appropriate testing varies by patient.

Health information published by Ask Dr. Hu is written and reviewed by Arizona naturopathic physicians with the goal of providing clear, practical, medically responsible patient education. Medical decisions should be based on an individualized evaluation rather than information from an educational article alone.

Published August 2026 | Medically reviewed August 2026

This information is for general educational purposes and does not replace individualized medical advice, diagnosis, or treatment and does not establish a physician-patient relationship.

About the Author

YiQiu Hu, NMD, is an Arizona-licensed naturopathic physician and founder of Ask Dr. Hu. He provides concierge medicine, preventive healthcare, health optimization, laboratory evaluation, hormone care, and individualized medical treatment for adults throughout Arizona.

Dr. Hu earned his Doctor of Naturopathic Medicine degree from Sonoran University of Health Sciences and a Bachelor of Science in Biomedical Sciences from Northern Arizona University. His clinical approach emphasizes comprehensive medical evaluation, thoughtful laboratory interpretation, evidence-informed decision-making, clear patient education, and individualized treatment planning.

Learn more about Dr. YiQiu Hu and the physicians at Ask Dr. Hu.